Below are the financial statements of Globus Medical, including the income statement and balance sheet for the company's latest fiscal year. All figures are accurate, verifiable, and fully traceable to the original annual filing where disclosed.
| All figures in millions of USD | 2024 2024-01-01 - 2024-12-31 | 2023 2023-01-01 - 2023-12-31 | 2022 2022-01-01 - 2022-12-31 |
|---|---|---|---|
| Net sales | 2,519.36a | 1,568.48a | 1,022.84a |
| Cost of sales and operating expenses | — | — | — |
| Cost of sales (exclusive of amortization of intangibles) | -1,035.48a | -548.17a | -263.73a |
| Research and development | -163.75a | -124.01a | -73.02a |
| Selling, general and administrative | -981.05a | -643.41a | -432.12a |
| Provision for litigation, net | -0.31a | -0.43a | -2.34a |
| Amortization of intangibles | -119.37a | -51.03a | -17.74a |
| Acquisition-related costs | -29.62a | -68.27a | -5.96a |
| Restructuring costs | -23.77a | 0a | 0a |
| Operating income/(loss) | 165.99a | 133.14a | 227.95a |
| Other income/(expense), net | — | — | — |
| Interest income/(expense), net | -4.19a | 20.13a | 14.23a |
| Foreign currency transaction gain/(loss) | -43.29a | 14.26a | -1.02a |
| Other income/(expense) | 2.21a | -2.14a | 1.86a |
| Total other income/(expense), net | -45.27a | 32.25a | 15.07a |
| Income/(loss) before income taxes | 120.72a | 165.39a | 243.02a |
| Income tax provision/(benefit) | -17.74a | -42.52a | -52.85a |
| Net income/(loss) | 102.98a | 122.87a | 190.17a |
Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Globus Medical’s data sources below and access millions more through our Disclosure Search.